Moderna

Moderna weekly uptrend opportunity based On 1.00 Lot Calculation:

• Moderna, Inc. a clinical-stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases.
• EVENT: Moderna began dosing the first participants in the Phase 1 study of mRNA-1283, the company’s latest Covid-19 vaccine candidate being developed as a potential refrigerator stable mRNA vaccine. New vaccine aims to facilitate easier distribution and administration by healthcare providers. mRNA-1283 is intended to be evaluated in futures studies for use as a booster dose for previously vaccinated or seropositive as well as in a primary series for seronegative individuals.
• Rival AstraZeneca Covid- 19 vaccines suspended in several EU countries. Moderna Covid- 19 vaccine possibly to benefit and gain bigger EU share (Denmark, Iceland, Norway, Austria and Germany had also suspended the use of AstraZeneca Covid-19 vaccine).
• Moderna launched a trial at 12 to 17 years old. 3000 are expected to be enrolled. The updated data could be expected to be released mid- year 2021. The largest population on Earth (around 30%) is below 16 so if all goes well this could prove to be a big market for Moderna.

Moderna, March 16, 2021
Current Price: 145

Example of calculation based on weekly trend direction for 1.00 Lot*

* 1.00 lot is equivalent of 1000 units
** Calculations for exchange rate used as of 11:05 am GMT 16/03/2021
Fortrade recommends the use of Stop-Loss and Take-Profit, please speak to your Client Manager regarding their use.
*** You may wish to consider closing your position in profit, even if it is lower than suggested one
**** Trailing stop technique can protect the profit – Ask your Client Manager for more detail